FDA Suggests Alternatives for Demonstrating CGMP Compliance for Combination Products

The FDA released a list of alternative suggestions for complying with CGMP requirements for drug combination products that covers stability testing, release for distribution, reserve samples and special testing requirements.
Source: Drug Industry Daily